Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 vs GHRP-6 Acetate: Research Application Comparison

Mechanism GHRH receptor agonist with albumin binding (DAC modification) Ghrelin receptor agonist (GHS-R1a) with somatostatin suppression CJC-1295 enhances endogenous rhythm; GHRP-6 overrides it Half-Life 6–8 days (plasma-bound) 20–30 minutes (rapid renal clear

This comparison does not assign a generated winner or score.

  • Mechanism
  • GHRH receptor agonist with albumin binding (DAC modification)
  • Ghrelin receptor agonist (GHS-R1a) with somatostatin suppression
  • CJC-1295 enhances endogenous rhythm; GHRP-6 overrides it
  • Half-Life
  • 6–8 days (plasma-bound)
  • 20–30 minutes (rapid renal clearance)
  • CJC-1295 eliminates daily dosing; GHRP-6 requires 2–3×/day
  • Peak GH Response
  • 2–3× baseline sustained 168+ hours
  • 5–15× baseline for 2–4 hours
  • GHRP-6 produces sharper spikes; CJC-1295 sustains elevation
  • IGF-1 Elevation
  • 1.5–3× baseline across 7 days
  • 1.2–2× baseline during active dosing only
  • CJC-1295 maintains anabolic signalling between doses
  • Dosing Frequency
  • Once per 5–7 days
  • 2–3 times daily
  • CJC-1295 suits long-term studies; GHRP-6 suits acute protocols
  • Appetite Effect
  • Minimal to none
  • Marked hunger within 20–40 minutes
  • GHRP-6 complicates metabolic research; CJC-1295 does not
  • Injection Site Reactions
  • 10–15% transient erythema
  • 8–12% transient erythema
  • Comparable. Neither peptide presents significant local tolerance issues
  • Cost Per Week (Research-Grade)
  • $40–70 for 1–2 mg/week
  • $60–90 for 14–21 doses/week
  • CJC-1295 offers superior cost-efficiency at equivalent GH exposure
  • Reconstituted Stability
  • 28 days at 2–8°C
  • 14 days at 2–8°C
  • CJC-1295 reduces wastage in multi-week protocols
  • Bottom Line
  • Best for sustained anabolic research, compliance-sensitive protocols, and studies requiring stable IGF-1
  • Best for acute GH response studies, circadian rhythm research, and protocols designed around pulsatile secretion
  • CJC-1295 wins for convenience and metabolic neutrality; GHRP-6 wins for peak amplitude and acute mechanistic study
More references

Related material